现代妇产科进展2017，Vol.26Issue(8)：599-602,4.DOI:10.13283/j.cnki.xdfckjz.2017.08.009
496例腹壁子宫内膜异位症临床分析
A retrospective study 496 cases of abdominal wall endometriosis
张璐 1赵骏达 2张绍芬 1邹世恩1
作者信息
- 1. 复旦大学附属妇产科医院妇科,上海 200011
- 2. 新疆医科大学第一附属医院妇科,乌鲁木齐 830054
- 折叠
摘要
Abstract
Objective:To investigate the clinical characters,treatment and prognosis of abdominal wall endometriosis(AWE).Methods:A retrospective study was conducted on women diagnosed with AWE at Obstetrics & Gynecology Hospital of Fudan University from Jan.2007 to Dec.2016.Data on Patient age,previous operations,symptoms,time-gap between last surgery and onset of symptoms,mass location,size,diagnoses,treatment and recurrence were analyzed.Results:A total of 496 patients were analyzed in the present cross-sectional study (mean age 31.4±4 years).All the patients had cesarean section history except for one who had a history of hysteromyomectomy.The primary clinical presentations were abdominal pain (94.6%) and masses (90.7%).All the patients received surgical therapy,of which 20.1% required mesh for fascial closure.29.6% (147 patients) received medical therapy post-operatively.The total recurrence rate was 4.9% (21/421),and the recurrence rate of patients with multiple foci was significantly higher than those with single focus(11.6% vs 3.9%,P<0.05).Age and number of focus were considered to have a great influence on the development of recurrence while size and location of focus did not.The recurrence of patients who took medical therapy post-operatively was slightly lower than those who did not (3.6% vs 5.7%,P>0.05).Conclusion:Cesarean section is closely related with the development of AWE in China.Younger age and multiple foci may play an important role in the recurrence of AWE.Surgery is the primary treatment for AWE,while postoperative treatment has no significant effect on reducing the recurrence rate of AWE.关键词
腹壁子宫内膜异位症/剖宫产/子宫内膜异位症Key words
Abdominal wall endometriosis/Cesarean section/Endometriosis分类
医药卫生引用本文复制引用
张璐,赵骏达,张绍芬,邹世恩..496例腹壁子宫内膜异位症临床分析[J].现代妇产科进展,2017,26(8):599-602,4.
